Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Janson Trieu"'
Autor:
Ruey-Shyang Soong, Liwen Song, Janson Trieu, Sung Yong Lee, Liangmei He, Ya-Chea Tsai, T-C Wu, Chien-Fu Hung
Publikováno v:
PLoS ONE, Vol 9, Iss 3, p e93162 (2014)
CD40 and CD40 ligand (CD40L) are costimulatory molecules that play a pivotal role in the proinflammatory immune response. Primarily expressed by activated CD4+ T cells, CD40L binds to CD40 on antigen presenting cells (APCs), thereby inducing APC acti
Externí odkaz:
https://doaj.org/article/ad8ae657061a45d9b6e784ac6b1741de
Autor:
Ruey-Shyang Soong, Janson Trieu, Sung Yong Lee, Liangmei He, Ya-Chea Tsai, T-C Wu, Chien-Fu Hung
Publikováno v:
PLoS ONE, Vol 8, Iss 2, p e56912 (2013)
The pivotal role of p53 as a tumor suppressor protein is illustrated by the fact that this protein is found mutated in more than 50% of human cancers. In most cases, mutations in p53 greatly increase the otherwise short half-life of this protein in n
Externí odkaz:
https://doaj.org/article/f3033645d74a4a7b8c8aa6a1eadeb96a
Autor:
Janson Trieu, Mark Chang, Vanessa Rojas, Neilmegh Varada, Yen Cao, Michael Anderson, Nicholas J. Vogelzang
Publikováno v:
Clinical Genitourinary Cancer. 20:399-403
The phase 3 trial ERA223 demonstrated an increased fracture rate and no survival advantage for metastatic castration resistant prostate cancer (mCRPC) patients on Radium-223 (Ra-223) with abiraterone, leading to regulatory restrictions on combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::14674a646b30dc6c907197a551d5d2eb
https://doi.org/10.1016/j.clgc.2022.04.015
https://doi.org/10.1016/j.clgc.2022.04.015
Autor:
Chien-Fu Hung, Cornelia L. Trimble, T.-C. Wu, Richard B.S. Roden, Wen-Fang Cheng, Yung-Nien Chang, Warner Huh, Ya-Chea Tsai, Liangmei He, Jayne Knoff, Janson Trieu, Liwen Song, Ruey-Shyang Soong
PDF file - 81K, Characterization of tumor infiltrating T cells following treatment with systemic DNA vaccination and locally applied imiquimod.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2aa3471f402bd0a77b327508969b4f7
https://doi.org/10.1158/1078-0432.22460306.v1
https://doi.org/10.1158/1078-0432.22460306.v1
Autor:
Chien-Fu Hung, Cornelia L. Trimble, T.-C. Wu, Richard B.S. Roden, Wen-Fang Cheng, Yung-Nien Chang, Warner Huh, Ya-Chea Tsai, Liangmei He, Jayne Knoff, Janson Trieu, Liwen Song, Ruey-Shyang Soong
Supplemental Figure Legend
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8365f620c7fee9426ca2de3c4fbc4d8
https://doi.org/10.1158/1078-0432.22460309.v1
https://doi.org/10.1158/1078-0432.22460309.v1
Autor:
Chien-Fu Hung, Cornelia L. Trimble, T.-C. Wu, Richard B.S. Roden, Wen-Fang Cheng, Yung-Nien Chang, Warner Huh, Ya-Chea Tsai, Liangmei He, Jayne Knoff, Janson Trieu, Liwen Song, Ruey-Shyang Soong
Purpose: Imiquimod is a Toll-like receptor 7 agonist used topically to treat external genital warts and basal cell carcinoma. We examined the combination of topical imiquimod with intramuscular administration of CRT/E7, a therapeutic human papillomav
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10c92870302afe54af890bf3da857e94
https://doi.org/10.1158/1078-0432.c.6524459
https://doi.org/10.1158/1078-0432.c.6524459
Autor:
Chien-Fu Hung, Cornelia L. Trimble, T.-C. Wu, Richard B.S. Roden, Wen-Fang Cheng, Yung-Nien Chang, Warner Huh, Ya-Chea Tsai, Liangmei He, Jayne Knoff, Janson Trieu, Liwen Song, Ruey-Shyang Soong
PDF file - 70K, E7-specific T cells efficiently migrated from circulation to the genital tract following imiquimod application.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4afc67e8af5fc5b4e61f3d33752affb4
https://doi.org/10.1158/1078-0432.22460318.v1
https://doi.org/10.1158/1078-0432.22460318.v1
Autor:
Kyrillus Samaan Shohdy, Dario Martin Villamar, Yen Cao, Janson Trieu, Kristin Sedgwick Price, Rebecca Nagy, Scott T. Tagawa, Ana M. Molina, Cora N. Sternberg, David M. Nanus, Petros Grivas, Guru P. Sonpavde, Juan Miguel Mosquera, Olivier Elemento, Nicholas J. Vogelzang, Bishoy Morris Faltas
Publikováno v:
Journal of Clinical Oncology. 40:532-532
532 Background: It is not known whether serial circulating tumor DNA (ctDNA) can augment imaging for assessing treatment response in patients (pts.) with advanced urothelial carcinoma (UC). We hypothesized that serial ctDNA measurements predict the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68f04849ce9c0775c50dd24657ebd848
https://doi.org/10.1200/jco.2022.40.6_suppl.532
https://doi.org/10.1200/jco.2022.40.6_suppl.532
Autor:
Emily Griffith, Curtiland Deville, Harleen Singh, T. DeWeese, Amol Narang, Carol Gergis, Todd McNutt, Stephen Greco, Phuoc T. Tran, Scott P. Robertson, Noura Radwan, Janson Trieu, Danny Y. Song, Theodore L. DeWeese, Anvesh Annadanam, Ashwin N. Ram, Stephanie Honig, Pei He
Publikováno v:
Prostate cancer and prostatic diseases
Background In men undergoing definitive radiation for prostate cancer, it is unclear whether early biochemical response can provide additional prognostic value beyond pre-treatment risk stratification. Methods Prostate cancer patients consecutively t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8726d7614adfe487039451fb7c4a22d
http://europepmc.org/articles/PMC5429233
http://europepmc.org/articles/PMC5429233
Autor:
Vanessa Rojas, Janson Trieu, Michael J. Anderson, Nicholas J. Vogelzang, Michael Elias, Yen Cao
Publikováno v:
Journal of Clinical Oncology. 38:5575-5575
5575 Background: Bone health agents (BHA) including denosumab, a monoclonal antibody, and Zoledronic acid (ZA), a bisphosphonate, are recommended for men with CRPC and bone metastases to prevent skeletal-related complications. ONJ occurs in about 5%
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0e9f421007b497a7979e20bd08cde25d
https://doi.org/10.1200/jco.2020.38.15_suppl.5575
https://doi.org/10.1200/jco.2020.38.15_suppl.5575